Vit D
Drug20 mg/day
Other names: Vitamin D
NCT Number: NCT02582892
Vitamin D plays an essential role in calcium homeostasis and is critical for bone formation and remodeling.
Looking for future studies?
Notify Me3 month–5 year
Female
Interventional
Phase 4
Gynelogical Center, Fortaleza, Ceará, Brazil
Evidence has demonstrated that vitamin D deficiency plays an important role in dental implants outcomes.
Low serum levels of Vitamin D is considered as a risk factor, not only for low mineral bone density but also in other metabolic pathways such as those involved in immune response and chronic inflammatory diseases.
There are few studies demonstrating the role that vitamin D deficiency in the etiopathogenesis of oral diseases and the consequences in Dental Implants.
Dentists have not yet well understood the importance of a good bone metabolism response for a successful bone regeneration and osseointegration of implants.
An insufficient bone response can not guarantee the necessary stability of the implants placed in it, has been one of the biggest problems of implantology.
Thus, the aim of this study is to evaluate the efficacy of Systemic vitamin D supplementation in menopausal women cadidates for dental implants.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
20 mg/day
Other names: Vitamin D
Time frame: 2 years
VIT D Serum levels
Time frame: 2 years
Densitometry in patients femur bones
University Potiguar
Other
Systemic Vitamin D Supplementation in Menopausal Women With Dental Implants
Acronym: VitaminD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07725081
Attitudes, Behavior
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT05541432
Behavior, Bone Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT03924414
Atypical Parkinsonism, Autonomic Nervous System Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT02924545
Bone Diseases, Bone Diseases, Metabolic
Nîmes, France
View Trial Details